BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 32553749)

  • 21. Analysis of Risk Alleles and Complement Activation Levels in Familial and Non-Familial Age-Related Macular Degeneration.
    Saksens NT; Lechanteur YT; Verbakel SK; Groenewoud JM; Daha MR; Schick T; Fauser S; Boon CJ; Hoyng CB; den Hollander AI
    PLoS One; 2016; 11(6):e0144367. PubMed ID: 27258093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic variants in the adenosine triphosphate-binding cassette transporter A1 and risk of age-related macular degeneration.
    Nordestgaard LT; Christoffersen M; Afzal S; Nordestgaard BG; Tybjærg-Hansen A; Frikke-Schmidt R
    Eur J Epidemiol; 2023 Sep; 38(9):985-994. PubMed ID: 37335386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration.
    Chen W; Stambolian D; Edwards AO; Branham KE; Othman M; Jakobsdottir J; Tosakulwong N; Pericak-Vance MA; Campochiaro PA; Klein ML; Tan PL; Conley YP; Kanda A; Kopplin L; Li Y; Augustaitis KJ; Karoukis AJ; Scott WK; Agarwal A; Kovach JL; Schwartz SG; Postel EA; Brooks M; Baratz KH; Brown WL; ; Brucker AJ; Orlin A; Brown G; Ho A; Regillo C; Donoso L; Tian L; Kaderli B; Hadley D; Hagstrom SA; Peachey NS; Klein R; Klein BE; Gotoh N; Yamashiro K; Ferris Iii F; Fagerness JA; Reynolds R; Farrer LA; Kim IK; Miller JW; Cortón M; Carracedo A; Sanchez-Salorio M; Pugh EW; Doheny KF; Brion M; Deangelis MM; Weeks DE; Zack DJ; Chew EY; Heckenlively JR; Yoshimura N; Iyengar SK; Francis PJ; Katsanis N; Seddon JM; Haines JL; Gorin MB; Abecasis GR; Swaroop A
    Proc Natl Acad Sci U S A; 2010 Apr; 107(16):7401-6. PubMed ID: 20385819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Associations of cholesteryl ester transfer protein (CETP) gene variants with predisposition to age-related macular degeneration.
    Liutkeviciene R; Vilkeviciute A; Streleckiene G; Kriauciuniene L; Chaleckis R; Deltuva VP
    Gene; 2017 Dec; 636():30-35. PubMed ID: 28918250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of high-density lipoprotein and apolipoprotein E genetic variants with age-related macular degeneration.
    Cezario SM; Calastri MC; Oliveira CI; Carmo TS; Pinhel MA; Godoy MF; Jorge R; Cotrim CC; Souza DR; Siqueira RC
    Arq Bras Oftalmol; 2015; 78(2):85-8. PubMed ID: 25945528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolomics in serum of patients with non-advanced age-related macular degeneration reveals aberrations in the glutamine pathway.
    Kersten E; Dammeier S; Ajana S; Groenewoud JMM; Codrea M; Klose F; Lechanteur YT; Fauser S; Ueffing M; Delcourt C; Hoyng CB; de Jong EK; den Hollander AI;
    PLoS One; 2019; 14(6):e0218457. PubMed ID: 31220133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Semi-Quantitative Multiplex Profiling of the Complement System Identifies Associations of Complement Proteins with Genetic Variants and Metabolites in Age-Related Macular Degeneration.
    Acar IE; Willems E; Kersten E; Keizer-Garritsen J; Kragt E; Bakker B; Galesloot TE; Hoyng CB; Fauser S; van Gool AJ; Lechanteur YTE; Koertvely E; Nogoceke E; Gloerich J; de Jonge MI; Lorés-Motta L; den Hollander AI
    J Pers Med; 2021 Nov; 11(12):. PubMed ID: 34945728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic Metabolomics in a Framework of Genetics and Lifestyle in Age-Related Macular Degeneration.
    Thee EF; Acar İE; Colijn JM; Meester-Smoor MA; Verzijden T; Baart SJ; Jarboui MA; Fauser S; Hoyng CB; Ueffing M; den Hollander AI; Klaver CCW;
    Metabolites; 2023 May; 13(6):. PubMed ID: 37367859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of genetic polymorphisms and age-related macular degeneration in Chinese population.
    Tian J; Yu W; Qin X; Fang K; Chen Q; Hou J; Li J; Chen D; Hu Y; Li X
    Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):4262-9. PubMed ID: 22618592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymorphisms in C2, CFB and C3 are associated with progression to advanced age related macular degeneration associated with visual loss.
    Francis PJ; Hamon SC; Ott J; Weleber RG; Klein ML
    J Med Genet; 2009 May; 46(5):300-7. PubMed ID: 19015224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human plasma metabolomics in age-related macular degeneration (AMD) using nuclear magnetic resonance spectroscopy.
    Laíns I; Duarte D; Barros AS; Martins AS; Gil J; Miller JB; Marques M; Mesquita T; Kim IK; Cachulo MDL; Vavvas D; Carreira IM; Murta JN; Silva R; Miller JW; Husain D; Gil AM
    PLoS One; 2017; 12(5):e0177749. PubMed ID: 28542375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioactive lysophospholipids generated by hepatic lipase degradation of lipoproteins lead to complement activation via the classical pathway.
    Ma W; Paik DC; Barile GR
    Invest Ophthalmol Vis Sci; 2014 Sep; 55(10):6187-93. PubMed ID: 25205869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spatial Distribution of Missense Variants within Complement Proteins Associates with Age Related Macular Degeneration.
    Grunin M; de Jong S; Palmer EL; Jin B; Rinker D; Moth C; Capra A; Haines JL; Bush WS; den Hollander AI;
    medRxiv; 2023 Aug; ():. PubMed ID: 37693462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urine Nuclear Magnetic Resonance (NMR) Metabolomics in Age-Related Macular Degeneration.
    Laíns I; Duarte D; Barros AS; Martins AS; Carneiro TJ; Gil JQ; Miller JB; Marques M; Mesquita TS; Barreto P; Kim IK; da Luz Cachulo M; Vavvas DG; Carreira IM; Murta JN; Silva R; Miller JW; Husain D; Gil AM
    J Proteome Res; 2019 Mar; 18(3):1278-1288. PubMed ID: 30672297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma Metabolomics of Intermediate and Neovascular Age-Related Macular Degeneration Patients.
    Mitchell SL; Ma C; Scott WK; Agarwal A; Pericak-Vance MA; Haines JL; Jones DP; Uppal K; Brantley MA
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complement Activation Levels Are Related to Disease Stage in AMD.
    Heesterbeek TJ; Lechanteur YTE; Lorés-Motta L; Schick T; Daha MR; Altay L; Liakopoulos S; Smailhodzic D; den Hollander AI; Hoyng CB; de Jong EK; Klevering BJ
    Invest Ophthalmol Vis Sci; 2020 Mar; 61(3):18. PubMed ID: 32176267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human Plasma Metabolomics Study across All Stages of Age-Related Macular Degeneration Identifies Potential Lipid Biomarkers.
    Laíns I; Kelly RS; Miller JB; Silva R; Vavvas DG; Kim IK; Murta JN; Lasky-Su J; Miller JW; Husain D
    Ophthalmology; 2018 Feb; 125(2):245-254. PubMed ID: 28916333
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of eight serum lipid biomarkers on age-related macular degeneration risk: a Mendelian randomization study.
    Han X; Ong JS; Hewitt AW; Gharahkhani P; MacGregor S
    Int J Epidemiol; 2021 Mar; 50(1):325-336. PubMed ID: 33211829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic association of apolipoprotein E with age-related macular degeneration.
    Klaver CC; Kliffen M; van Duijn CM; Hofman A; Cruts M; Grobbee DE; van Broeckhoven C; de Jong PT
    Am J Hum Genet; 1998 Jul; 63(1):200-6. PubMed ID: 9634502
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.